{"schema_version":"secwatch.filing_event.v1","accession":"0001699350-25-000008","form_type":"8-K","ticker":"SI","cik":"0001699350","company_name":"SHOULDER INNOVATIONS, INC.","filed_at":"2025-09-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.705115+00:00","generated_at":"2026-05-17T07:19:15.410325+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Shoulder Innovations Q2 revenue $11M (+33% YoY); FY2025 guidance $42-44M","bullets":["Q2 net revenue $11.0M, up 33% YoY; gross margin 76.2% (vs 76.9%).","Net loss $19.2M vs $4.2M loss in Q2 2024, driven by $13.1M fair value charge on warrant liability and purchase option.","FY2025 revenue guidance $42M-$44M, implying ~33-39% growth over FY2024.","Raised $115M total gross proceeds from IPO ($75M) and convertible notes ($40M) in July/Aug 2025.","Appointed Rick Buchholz to board; launched InSet 70 humeral stem product."],"urls":{"canonical":"https://secwatch.observer/filing/0001699350-25-000008","json":"https://secwatch.observer/filing/0001699350-25-000008.json","markdown":"https://secwatch.observer/filing/0001699350-25-000008.md","text":"https://secwatch.observer/filing/0001699350-25-000008.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1699350/000169935025000008/0001699350-25-000008-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1699350/000169935025000008/si-20250909.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T07:19:15.410325+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}